Technical Analysis for IIQ - INOVIQ Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Reversal New Lows Setup | Bearish Swing Setup | 2.00% | |
Volume Surge | Other | 2.00% | |
Lower Bollinger Band Touch | Weakness | 2.00% | |
Oversold Stochastic | Weakness | 2.00% | |
Narrow Range Bar | Range Contraction | -3.77% | |
Inside Day | Range Contraction | -3.77% | |
Oversold Stochastic | Weakness | -3.77% | |
Stochastic Buy Signal | Bullish | -2.86% |
Alert | Time |
---|---|
Possible Inside Day | about 8 hours ago |
Up 2% | about 10 hours ago |
Up 1% | about 10 hours ago |
Up 3% | about 10 hours ago |
Down 1 ATR | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Cancers Breast Cancer Diagnostic Products Infectious Causes Of Cancer Prostate Cancer Anatomy Exosome
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Cancers Breast Cancer Diagnostic Products Infectious Causes Of Cancer Prostate Cancer Anatomy Exosome
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|---|
Mar 23 | A Look At The Fair Value Of INOVIQ Ltd (ASX:IIQ) |
Indicator | Value |
---|---|
52 Week High | 0.99 |
52 Week Low | 0.465 |
Average Volume | 120,724 |
200-Day Moving Average | 0.631 |
50-Day Moving Average | 0.604 |
20-Day Moving Average | 0.566 |
10-Day Moving Average | 0.545 |
Average True Range | 0.032 |
RSI (14) | 38.65 |
ADX | 13.56 |
+DI | 22.718 |
-DI | 32.267 |
Chandelier Exit (Long, 3 ATRs) | 0.619 |
Chandelier Exit (Short, 3 ATRs) | 0.581 |
Upper Bollinger Bands | 0.648 |
Lower Bollinger Band | 0.484 |
Percent B (%b) | 0.16 |
BandWidth | 28.950 |
MACD Line | -0.022 |
MACD Signal Line | -0.014 |
MACD Histogram | -0.0078 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.540 | ||||
Resistance 3 (R3) | 0.540 | 0.530 | 0.535 | ||
Resistance 2 (R2) | 0.530 | 0.522 | 0.530 | 0.533 | |
Resistance 1 (R1) | 0.520 | 0.518 | 0.525 | 0.520 | 0.532 |
Pivot Point | 0.510 | 0.510 | 0.513 | 0.510 | 0.510 |
Support 1 (S1) | 0.500 | 0.502 | 0.505 | 0.500 | 0.488 |
Support 2 (S2) | 0.490 | 0.498 | 0.490 | 0.487 | |
Support 3 (S3) | 0.480 | 0.490 | 0.485 | ||
Support 4 (S4) | 0.480 |